Pfizer
PFE
2,733 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,282 increasing their positions, 1,001 reducing their positions, and 97 closing their positions.
93% more first-time investments, than exits
New positions opened: 187 | Existing positions closed: 97
28% more repeat investments, than reductions
Existing positions increased: 1,282 | Existing positions reduced: 1,001
27% more funds holding in top 10
Funds holding in top 10: 55 → 70 (+15)
9% more capital invested
Capital invested by funds: $133B → $145B (+$12.5B)
2% more funds holding
Funds holding: 2,676 → 2,733 (+57)
0.55% more ownership
Funds ownership: 65.93% → 66.48% (+0.55%)
10% less call options, than puts
Call options by funds: $2.23B | Put options by funds: $2.47B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$393M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$356M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$206M |
| 4 |
D.E. Shaw & Co
New York
|
+$178M |
| 5 |
N
Natixis
Paris,
France
|
+$172M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$313M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$290M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$181M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$153M |
| 5 |
JP Morgan Chase
New York
|
-$143M |
PFE Hedge Fund Activity: Q2 2021 in Review
2,733 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2021, worth a combined $145B — up 9.4% from $133B a quarter earlier.
Buyers outnumbered sellers: 187 funds opened new PFE positions and 97 closed out — a net gain of 90 holders — while 1,282 added to existing stakes and 1,001 trimmed.
The largest buyer was Capital World Investors, adding an estimated $393M. The largest seller was Wellington Management Group, cutting an estimated $313M.
- 2,733 institutional investors held Pfizer (PFE) as of Q2 2021, up from 2,676 in Q1 2021.
- Funds reported $145B of Pfizer stock for Q2 2021, up 9.4% quarter-over-quarter.
- 187 funds opened new Pfizer positions in Q2 2021 and 97 closed out, a net change of +90 holders.
- The largest Pfizer buyer in Q2 2021 was Capital World Investors, an estimated $393M added.
- The largest Pfizer seller in Q2 2021 was Wellington Management Group, an estimated $313M sold.
Based on aggregated 13F filings for Q2 2021.